A putative counter-receptor of B7-H3 appears to be expressed during early phases of T cell activation and CTLA-4, ICOS and PD-1—three known inducible receptors of the B7 family—can be excluded.

Accord shares how cardiovascular risk impacts long-term patient outcomes in cancer care and how many survivors are at an ...